Daniel C. Javitt MD PhD
Psychopharmacology
Director, Division of Experimental Therapeutics Director, Columbia Conte Center for Schizophrenia Research Professor of Psychiatry and Neuroscience Columbia University College of Physicians and Surgeons New York, NY Director, Division of Schizophrenia Research Nathan Kline Institute for Psychiatric Research Orangeburg, NY
Join to View Full Profile
1051 Riverside DrUnit 21New York, NY 10032
Phone+1 212-543-5475
Fax+1 212-543-5668
Dr. Javitt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Psychiatry, 1986 - 1987- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Psychiatry, 1984 - 1986
Albert Einstein College of MedicineClass of 1983
Certifications & Licensure
NY State Medical License 1984 - 2025
MD State Medical License 2009 - 2010
American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Safety and Effectiveness of D-serine in Schizophrenia Start of enrollment: 2006 Mar 01
- A Multicenter Study of NAP (AL-108) in Schizophrenia Start of enrollment: 2007 Jul 01
- Sodium Oxybate in Schizophrenia With Insomnia Start of enrollment: 2008 May 01
- Join now to see all
Publications & Presentations
PubMed
- Impact of Early Auditory Processing on Negative Symptom Response to Cognitive Remediation for Schizophrenia.Alice M Saperstein, Ryan Brennan, Min Qian, Daniel C Javitt, Alice Medalia
Schizophrenia Bulletin. 2025-02-21 - Lower-level oculomotor deficits in schizophrenia during multi-line reading: Evidence from return-sweeps.Andriana L Christofalos, Madison Laks, Stephanie Wolfer, Elisa C Dias, Daniel C Javitt
Quarterly Journal of Experimental Psychology. 2024-07-01 - Biomarkers for Cognitive Control, Response Inhibition, Aggressivity, Impulsivity, and Violence.Matthew J Hoptman, Ragy R Girgis, Daniel C Javitt
Advances in Neurobiology. 2024-01-01
Journal Articles
- A Multicenter Study of Ketamine Effects on Functional Connectivity: Large Scale Network Relationships, Hubs and Symptom MechanismsRagy R Girgis, Richard J Maddock, John D Ragland, Daniel C Javitt, Cameron S Carter, Joshua T Kantrowitz, Jeffrey Lieberman, John H Krystal, Lawrence S Kegeles, Willia..., ScienceDirect
- American Psychiatric Association PublishingCheryl M Corcoran, Daniel C Javitt, National Institutes of Health
- Sensory and Cross-Network Contributions to Response Inhibition in Patients with SchizophreniaDaniel C Javitt, Matthew J Hoptman, ScienceDirect
Press Mentions
Pharma Consortium Publishes Results of Large EEG/ERP Biomarker Study in Subjects with Schizophrenia and Healthy VolunteersMarch 16th, 2023- CUIMC Update - Sept. 13, 2021September 13th, 2021
- NRx Pharmaceuticals, Inc. Commences Trading on Nasdaq as NRXP, Following Merger Between NeuroRx, Inc. And Big Rock Partners Acquisition Corp (Nasdaq:BRPA)May 25th, 2021
- Join now to see all
Grant Support
- A Schizophrenia Extension Study for the NKI Rockland Sample II project: An Open Resource of Multimodal Brain, Physiology & Behavior from a Community Lifespan SampleNATHAN S. KLINE INSTITUTE FOR PSYCH RES2024–2029
- Use of alpha-frequency deep transcranial interference stimulation (tIS) to understand and modify temporal dynamics of face emotion recognition and social/affective function.COLUMBIA UNIVERSITY HEALTH SCIENCES2024–2028
- Auditory event-related potentials as in vivo preclinical assays of circuit engagement for E/I-based therapeutic developmentNATHAN S. KLINE INSTITUTE FOR PSYCH RES2023–2028
- Glutamatergic mechanisms of psychosis and target engagementNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC2020–2027
- Neural Mechanisms of Reading Dysfunction in SchizophreniaCOLUMBIA UNIVERSITY HEALTH SCIENCES2020–2025
- Neural Mechanisms of Reading Dysfunction in SchizophreniaCOLUMBIA UNIVERSITY HEALTH SCIENCES2020–2025
- Neural Mechanisms of Reading Dysfunction in SchizophreniaCOLUMBIA UNIVERSITY HEALTH SCIENCES2020–2025
- Neural Mechanisms of Reading Dysfunction in SchizophreniaCOLUMBIA UNIVERSITY HEALTH SCIENCES2020–2025
- Early Cortical Processing in SchizophreniaNATHAN S. KLINE INSTITUTE FOR PSYCH RES1993–2025
- Early Cortical Processing In SchizophreniaNational Institute Of Mental Health2003–2012
- Multimodal Assessment Of Sensory Processing Dysfunction In SchizophreniaNational Institute Of Mental Health2011
- AdministrativeNational Institute Of Mental Health2011
- The Conte Center For Schizophrenia ResearchNational Institute Of Mental Health2010–2011
- The Conte Center For Schizophrenia ResearchNational Institute Of Mental Health2009–2010
- Multimodal Assessment Of Sensory Processing Dysfunction In SchizophreniaNational Institute Of Mental Health2009–2010
- AdministrativeNational Institute Of Mental Health2009–2010
- Sensory Processing Dysfunction In Neuropsychiatric IllnessNational Institute Of Mental Health2008–2010
- Phencyclidine Abuse &Psychosis: Biomedical MechanismsNational Institute On Drug Abuse2007–2010
- Pk/Pd, Dose Finding And Adjunctive Treatment StudiesNational Institute Of Mental Health2005–2009
- D-Serine Treatment Of SchizophreniaNational Institute Of Mental Health2005–2009
- Methods For Sensory Assessment In SchizophreniaNational Institute Of Mental Health2008
- Dopamine In A Primate Model Of Glutamate HypofunctionNational Institute Of Mental Health2004–2008
- Neurophysiological NMDA Dysfunction In SchizophreniaNational Institute Of Mental Health1997–2006
- Phencyclidine Abuse And Psychoses: Biomedical MechanismsNational Institute On Drug Abuse2001–2005
- Mechanisms Of Cognitive Dysfunction In SchizophreniaNational Institute Of Mental Health2001–2005
- Neuroanatomic Basis Of Cognitive ERP Deficit In SchizophFogarty International Center2001–2003
- Treatment Of Negative Symptoms And Cognitive ImpairmentsNational Institute Of Mental Health2000–2003
- High-Density ERP Mapping &FmriNational Center For Research Resources2002
- Phencyclidine Abuse And Psychosis--Biomedical MechanismsNational Institute On Drug Abuse1998–2000
- Intracortical Mechanisms Of COG Dysfunction In SchizophrNational Institute Of Mental Health1997–1999
- Early Cortical Processing In SchizophreniaNational Institute Of Mental Health1996–1997
- Assessment Of Glycine Treatment In SchizophreniaNational Institute Of Mental Health1996–1997
- Phencyclidine Abuse &Psychosis--Biomedical MechanismsNational Institute On Drug Abuse1995
- Early Cortical Processing In SchizophreniaNational Institute Of Mental Health1995
- Early Cortical Processing In SchizophreniaNational Institute Of Mental Health1993–1995
- NMDA Receptors In Processing Contingent Aep GenerationNational Institute Of Mental Health1990–1991
- Phencyclidine Psychopharmacology--SchizophreniaNational Institute Of Mental Health1986–1990
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
